science

It looks like the hormonal NES/T male contraceptive gel passed safety a while back and started phase 2 trials in 2018. It's already gearing up for phase 3 trials with investors ready to fund this final phase:
https://www.einpresswire.com/article/835140008/contraline-exercises-license-option-for-nes-t-the-first-male-contraceptive-to-reach-late-stage-development

But a hormone-free option is more appealing. I hope YCT-529 makes it to the finish line.